{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Management of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Distinguish between endometrioid intraepithelial neoplasia (EIN) and endometrial hyperplasia classification systems.
  2. Outline diagnostic methods used in the work-up of EIN.
  3. Explain patient-centered medical and surgical treatment of EIN.

Learning Outcomes

By the conclusion of this activity, a majority of the participants will demonstrate knowledge of the diagnosis and management of endometrioid intraepithelial neoplasia (EIN) by achieving a passing score on the posttest.
Price: $49.00

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CEH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: PGO0525B
Published: May 2025
Expires: 6/4/2027
Required Passing Score: 8/10 (80%)
Authors: Kelsey C. Goon, MD; Jennifer Bennett, MD; Sarah A. Ackroyd, MD, MPH